ArticleBMC health services research2026
Evaluating departmental performance and reimbursement-cost pricing distortions under DRG-based payment: evidence from a tertiary hospital in China.
Article in BMC health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiagnosis-Related Group (DRG)-based payment reform aims to improve efficiency and restrain unnecessary expenditure, yet routine hospital indicators often report case mix, cost deviation, and profitability separately. This separation may obscure whether an unfavorable departmental profile reflects low cost-adjusted weighted output, reimbursement-cost misalignment, or an adverse position within the complexity-profitability distribution.
objectiveThis study develops and applies a DRG-Based Profitability-Efficiency Mapping (DRG-PEM) framework to evaluate departmental performance and identify reimbursement-cost pricing distortions within a DRG-based payment system.
methodsA retrospective analysis was conducted using discharge and cost data from 29 clinical departments in a large tertiary general hospital in China between January and June 2022. The analytical workbook contained 25,379 discharges, 1,962 department-DRG group records, and 595 unique DRG codes. DRG-PEM integrates three sequential modules: the Structural Efficiency Score (SES), the Weight-Cost Deviation Index (WCDI), and a DRG profitability-complexity quadrant map. Scenario simulation was performed for high-deviation DRG groups meeting predefined criteria: baseline WCDI > 40%, theoretical reimbursement below observed cost, complete cost data, and stable department-level case volume.
resultsSES values ranged from 23.86 in Pulmonary Medicine to 71.38 in Stomatology, demonstrating substantial interdepartmental heterogeneity. WCDI values ranged from 31.77% in Urology to 84.56% in Stomatology; similarly high values were observed in Pediatrics (83.72%), Pain Medicine (76.51%), and Anorectal Traditional Chinese Medicine (63.75%). Directional financial indicators showed that high WCDI did not uniformly indicate under-reimbursement: Stomatology had high WCDI but positive average profit per case, whereas ICU combined high CMI (1.81), negative average profit per case (-¥11,286.44), and severe WCDI (46.07%). Scenario simulations showed that reimbursement-to-cost ratios improved after hypothetical weight increases but remained below 1.0 for several high-deviation groups.
conclusionsDRG-PEM provides an implementable department-level framework for distinguishing cost-adjusted weighted output, reimbursement deviation, and structural financial risk under DRG payment. The framework supports integrated assessment of departmental performance and can inform targeted DRG weight adjustment, cost control, and internal resource allocation and institutional operational governance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.